Studies in Meta-analyses (continued, 4)

This Clinical Practice Guideline used the references below in meta-analyses of research on treating tobacco use and dependence.

Table 6.28. Meta-analysis (2008): Effectiveness and abstinence rates of medications relative to the nicotine patch (n = 86 studies)

Abelin T, Buehler A, Muller P, et al. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989;1:7-10.

Ahluwalia JS, Harris KJ, Catley D, et al. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA 2002;288:468-74.

Ahluwalia JS, Okuyemi K, Nollen N, et al. The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Addiction 2006;101:883-91.

Ahluwalia JS, McNagny SE, Clark WS. Smoking cessation among inner-city African Americans using the nicotine transdermal patch. J Gen Intern Med 1998;13:1-8.

Ahmadi J, Ashkani H, Ahmadi M, et al. Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone. J Subst Abuse Treat 2003;24:251-5.

Areechon W, Punnotok J. Smoking cessation through the use of nicotine chewing gum: a double-blind trial in Thailand. Clin Ther 1988;10:183-6.

Aubin HJ, Lebargy F, Berlin I, et al. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Addiction 2004;99:1206-18.

Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. Br Med J 1999;318:285-8.

Bohadana A, Nilsson F, Rasmussen T, et al. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000;160:3128-34.

Cinciripini PM, Tsoh JY, Wetter DW, et al. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Exp Clin Psychopharmacol 2005;13:282-92.

Collins BN, Wileyto EP, Patterson F, et al. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res 2004;6:27-37.

Cooper TV, Klesges RC, Debon MW, et al. A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict Behav 2005;30:61-75.

Covey LS, Glassman AH, Stetner F, et al. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 2002;159:1731-7.

Croghan GA, Sloan JA, Croghan IT, et al. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res 2003;5:181-7.

da Costa CL, Younes RN, Lourenco MT. Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo. Chest 2002;122:403-8.

Dalsgareth OJ, Hansen NC, Soes-Petersen U, et al. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. Nicotine Tob Res 2004;6:55-61.

Daughton D, Susman J, Sitorius M, et al. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska primary practice smoking cessation trial group. Arch Fam Med 1998;7:425-30.

Davidson M, Epstein M, Burt R, et al. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 1998;7:569-74.

Evins AE, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 2005;25:218-25.

Evins AE, Mays VK, Rigotti NA, et al. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 2001;3:397-403.

Fee WM, Stewart MJ. A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. Practitioner 1982;226:148-151.

* Fiore MC, Kenford SL, Jorenby DE, et al. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest 1994;105:524-33.

Fortmann SP, Killen JD, Telch MJ, et al. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford stop smoking project. JAMA 1988;260:1575-80.

George TP, Vessicchio JC, Termine A, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 2002;52:53-61.

Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993;54:670-9.

Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988;259:2863-6.

Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55.

Gonzales DH, Nides MA, Ferry LH, et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 2001;69:438-44.

Gourlay SG, Forbes A, Marriner T, et al. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. Br Med J 1995;311:363-6.

Haggstram FM, Chatkin JM, Sussenbach-Vaz E, et al. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. Pulm Pharmacol Ther 2006;19:205-9.

Hall SM, Humfleet GL, Reus VI, et al. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry 2004;161:2100-7.

Hall SM, Humfleet GL, Reus VI, et al. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 2002;59:930-6.

Hall SM, Munoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol 1996;64:1003-9.

Hall SM, Tunstall CD, Ginsberg D, et al. Nicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol 1987;55:603-5.

Hays JT, Croghan IT, Schroeder DR, et al. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health 1999;89:1701-7.

Herrera N, Franco R, Herrera L, et al. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995;108:447-51.

Hjalmarson A, Franzon M, Westin A, et al. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Intern Med 1994;154:2567-72.

Hjalmarson A, Nilsson F, Sjostrom L, et al. The nicotine inhaler in smoking cessation. Arch Intern Med 1997;157:1721-8.

Holt S, Timu-Parata C, Ryder-Lewis S, et al. Efficacy of bupropion in the indigenous Maori population in New Zealand. Thorax 2005;60:120-3.

Hughes JR, Lesmes GR, Hatsukami DK, et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1999;1:169-74.

Hughes JR, Novy P, Hatsukami DK, et al. Efficacy of nicotine patch in smokers with a history of alcoholism. Alcohol Clin Exp Res 2003;27:946-54.

Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 1994;271:595-600.

Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New Engl J Med 1997;337:1195-202.

Jensen EJ, Schmidt E, Pedersen B, et al. The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence. Int J Addict 1991;26:1223-31.

Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63.

Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New Engl J Med 1999;340:685-91.

Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New Engl J Med 1996;335:1792-8.

Killen JD, Fortmann SP, Davis L, et al. Nicotine patch and self-help video for cigarette smoking cessation. J Consult Clin Psychol 1997;65:663-72.

Killen JD, Fortmann SP, Murphy Jr GM, et al. Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol 2006;74:286-94.

Killen JD, Fortmann SP, Newman B, et al. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990;58:85-92.

Killen JD, Fortmann SP, Schatzberg AF, et al. Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psychol 2000;68:883-9.

Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995;24:41-7.

Leischow SJ, Nilsson F, Franzon M, et al. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav 1996;20(5):364-71.

Lewis SF, Piasecki TM, Fiore MC, et al. Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med 1998;27:296-303.

Myles PS, Leslie K, Angliss M, et al. Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial. Anaesthesia 2004;59:1053-8.

Niaura R, Spring B, Borrelli B, et al. Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol 2002;70:887-96.

Nides M, Oncken C, Gonzales D, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med 2006;166:1561-8.

Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 2006;166:1571-7.

Perng RP, Hsieh WC, Chen YM, et al. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. J Formos Med Assoc 1998;97:547-51.

Prochazka AV, Kick S, Steinbrunn C, et al. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Arch Intern Med 2004;164:2229-33.

Puska P, Korhonen HJ, Vartiainen E, et al. Combined use of nicotine patch and gum compared with gum alone in smoking cessation—a clinical trial in North Karelia. Tob Control 1995;4:231-5.

Richmond RL, Kehoe L, de Almeida Neto AC. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome. Addiction 1997;92:27-31.

Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993;153:1881-90.

* Schneider NG, Jarvik ME, Forsythe AB, et al. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 1983; 8:253-61.

Schneider NG, Olmstead R, Mody FV, et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995;90:1671-82.

Schneider NG, Olmstead R, Nilsson F, et al. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 1996;91:1293-306.

Simon JA, Duncan C, Carmody TP, et al. Bupropion for smoking cessation: a randomized trial. Arch Intern Med 2004;164:1797-803.

* Sonderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997;145:309-18.

Stapleton JA, Russell MA, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995;90:31-42.

Sutherland G, Stapleton JA, Russell MA, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.

Swanson NA, Burroughs CC, Long MA, et al. Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release bupropion, or both. Mil Med 2003;168:830-4.

Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001;357:1571-5.

Tonnesen P, Mikkelsen KL. Smoking cessation with four nicotine replacement regimes in a lung clinic. Eur Respir J 2000;16:717-22.

Tonnesen P, Norregaard J, Mikkelsen K, et al. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993;269:1268-71.

Tonnesen P, Norregaard J, Simonsen K, et al. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. New Engl J Med 1991;325:311-5.

Tonnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999;13:238-46.

Tonnesen P, Tonstad S, Hjalmarson A, et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med 2003;254:184-92.

Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J 2003;24:946-55.

Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-8.

Wagena EJ, Knipschild PG, Huibers MJ, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005;165:2286-92.

Westman EC, Levin ED, Rose JE. The nicotine patch in smoking cessation. A randomized trial with telephone counseling. Arch Intern Med 1993;153:1917-23.

Wong GY, Wolter TD, Croghan GA, et al. A randomized trial of naltrexone for smoking cessation. Addiction 1999;94:1227-37.

Zellweger JP, Boelcskei PL, Carrozzi L, et al. Bupropion SR vs placebo for smoking cessation in health care professionals. Am J Health Behav 2005;29:240-9.

Return to Contents

Table 6.29. Meta-analysis (2008): Effectiveness and abstinence rates for smokers not willing to quit (but willing to change their smoking patterns or reduce their smoking) after receiving nicotine replacement therapy compared to placebo (n = 5 studies)

Batra A, Klingler K, Landfeldt B, et al. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther 2005;78:689-96.

Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. Br Med J 2000;321:329-33.

Etter JF, Laszlo E, Zellweger JP, et al. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. J Clin Psychopharmacol 2002;22:487-95.

Rennard SI, Glover ED, Leischow S, et al. Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res 2006;8:555-64.

Wennike P, Danielsson T, Landfeldt B, et al. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 2003;98:1395-402.

Return to Contents

Table 6.30. Meta-analysis (2000): Effectiveness and estimated abstinence rates for over-the-counter nicotine patch therapy (n = 3 studies)

* Davidson M, Epstein M, Burt R, et al. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 1998;7(6):569-74.

Sonderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997;145(4):309-18.

Return to Contents

Table 6.31. Meta-analysis (2008): Effectiveness and estimated abstinence rates for clinician training (n = 2 studies)

Cornuz J, Humair JP, Seematter L, et al. Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients. Ann Intern Med 2002;136(6):429-37.

Sinclair HK, Bond CM, Lennox AS, et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998;7:253-61.

Return to Contents

Table 6.32. Meta-analysis (2008): Effectiveness of clinician training on rates of providing treatment ("Assist") (n = 2 studies)

Cornuz J, Humair JP, Seematter L, et al. Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients. Ann Intern Med 2002;136:429-37.

Sinclair HK, Bond CM, Lennox AS, et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998;7:253-61.

Return to Contents

Table 6.33. Meta-analysis (2008): Effectiveness of clinician training combined with charting on asking about smoking status ("Ask") (n = 3 studies)

Cummings SR, Coates TJ, Richard RJ, et al. Training physicians in counseling about smoking cessation. a randomized trial of the "quit for life" program. Ann Intern Med 1989;110(8):640-7.

Cummings SR, Richard RJ, Duncan CL, et al. Training physicians about smoking cessation: a controlled trial in private practice. J Gen Intern Med 1989;4:482-9.

Pbert L, Fletcher KE, Flint AJ, et al. Smoking prevention and cessation intervention delivery by pediatric providers, as assessed with patient exit interviews. Pediatrics 2006;118:e810-24.

Return to Contents

Table 6.34. Meta-analysis (2008): Effectiveness of training combined with charting on setting a quit date ("Assist") (n = 2 studies)

Cummings SR, Coates TJ, Richard RJ, et al. Training physicians in counseling about smoking cessation. A randomized trial of the "quit for life" program. Ann Intern Med 1989;110(8):640-7.

Cummings SR, Richard RJ, Duncan CL, et al. Training physicians about smoking cessation: a controlled trial in private practice. J Gen Intern Med 1989;4:482-9.

Return to Contents

Table 6.35. Meta-analysis (2008): Effectiveness of training combined with charting on providing materials ("Assist") (n = 2 studies)

Cummings SR, Coates TJ, Richard RJ, et al. Training physicians in counseling about smoking cessation. A randomized trial of the "quit for life" program. Ann Intern Med 1989;110(8):640-7.

Cummings SR, Richard RJ, Duncan CL, et al. Training physicians about smoking cessation: a controlled trial in private practice. J Gen Intern Med 1989;4:482-9.

Return to Contents

Table 6.36. Meta-analysis (2008): Effectiveness of training combined with charting on arranging for followup ("Arrange") (n = 2 studies)

Cummings SR, Coates TJ, Richard RJ, et al. Training physicians in counseling about smoking cessation. A randomized trial of the "quit for life" program. Ann Intern Med 1989;110(8):640-7.

Cummings SR, Richard RJ, Duncan CL, et al. Training physicians about smoking cessation: a controlled trial in private practice. J Gen Intern Med 1989;4:482-9.

Return to Contents

Table 6.37. Meta-analysis (2008): Estimated rates of intervention for individuals who received tobacco use interventions as a covered health insurance benefit (n = 3 studies)

Alesci NL, Boyle RG, Davidson G, et al. Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation? Am J Health Promot 2004;18:366-9.

Holtrop JS, Wadland WC, Vansen S, et al. Recruiting health plan members receiving pharmacotherapy into smoking cessation counseling. Am J Manag Care 2005;11:501-7.

Murphy JM, Mahoney MC, Cummings KM, et al. A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States). Cancer Causes Control 2005;16:373-82.

Return to Contents

Table 6.38. Meta-analysis (2008): Estimated rates of quit attempts for individuals who received tobacco use interventions as a covered health insurance benefit (n = 3 studies)

Alesci NL, Boyle RG, Davidson G, et al. Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation? Am J Health Promot 2004;18:366-9.

Holtrop JS, Wadland WC, Vansen S, et al. Recruiting health plan members receiving pharmacotherapy into smoking cessation counseling. Am J Manag Care 2005;11:501-7.

Murphy JM, Mahoney MC, Cummings KM, et al. A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States). Cancer Causes Control 2005;16:373-82.

Return to Contents

Table 6.39. Meta-analysis (2008): Estimated abstinence rates for individuals who received tobacco use interventions as a covered benefit (n = 3 studies)

Alesci NL, Boyle RG, Davidson G, et al. Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation? Am J Health Promot 2004;18:366-9.

Holtrop JS, Wadland WC, Vansen S, et al. Recruiting health plan members receiving pharmacotherapy into smoking cessation counseling. Am J Manag Care 2005;11:501-7.

Murphy JM, Mahoney MC, Cummings KM, et al. A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States). Cancer Causes Control 2005;16:373-82.

Return to Contents

Table 7.1. Evidence of effectiveness of tobacco dependence interventions in specific populations. Section 4, Low SES/limited formal education (n = 5 studies)

Curry SJ, Ludman EJ, Graham E, et al. Pediatric-based smoking cessation intervention for low-income women: a randomized trial. Arch Pediatr Adolesc Med 2003;157:295-302.

Davies SL, Kohler CL, Fish L, et al. Evaluation of an intervention for hospitalized African American smokers. Am J Health Behav 2005;29:228-39.

Groner JA, Ahijevych K, Grossman LK, et al. The impact of a brief intervention on maternal smoking behavior. Pediatrics 2000;105:267-71.

Solomon LJ, Marcy TW, Howe KD, et al. Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches? Prev Med 2005;40:306-13.

Solomon LJ, Scharoun GM, Flynn BS, et al. Free nicotine patches plus proactive telephone peer support to help low-income women stop smoking. Prev Med 2000;31:68-74.

Return to Contents

Table 7.1. Evidence of effectiveness of tobacco dependence interventions in specific populations. Section 7, Psychiatric disorders including substance use disorders. (n = 4 studies)

Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998;55:683-90.

Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999;174:173-8.

Smith SS, Jorenby DE, Leischow SJ, et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res 2003;5(1):99-109.

Wagena, EJ, Knipschild PG, Huibers MJ, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med (2005);165:2286-92.

Return to Contents

Table 7.4. Meta-analysis (2008): Effectiveness of and estimated abstinence rates for counseling interventions with adolescent smokers (n = 7 studies)

Brown RA, Ramsey SE, Strong DR, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Control 2003;12 Suppl 4:IV3-10.

Colby SM, Monti PM, O'Leary Tevyaw T, et al. Brief motivational intervention for adolescent smokers in medical settings. Addict Behav 2005;30:865-74.

Horn K, Dino G, Hamilton C, et al. Efficacy of an emergency department-based motivational teenage smoking intervention. Prev Chronic Dis 2007;4:A08.

Kelly AB, Lapworth K. The HYP program-targeted motivational interviewing for adolescent violations of school tobacco policy. Prev Med 2006;43(6):466-71.

Myers MG, Brown SA. A controlled study of a cigarette smoking cessation intervention for adolescents in substance abuse treatment. Psychol Addict Behav 2005;19:230-3.

Robinson LA, Vander Weg MW, Riedel BW, et al. "Start to stop:" results of a randomised controlled trial of a smoking cessation programme for teens. Tob Control 2003;12 Suppl 4:IV26-33.

Sussman S, Dent CW, Lichtman KL. Project EX: outcomes of a teen smoking cessation program. Addict Behav 2001;26:425-38.

Return to Contents

Table 7.5. Meta-analysis (2008): Effectiveness of and estimated pre-parturition abstinence rates for psychosocial interventions with pregnant smokers (n = 8 studies)

Albrecht SA, Caruthers D, Patrick T, et al. A randomized controlled trial of a smoking cessation intervention for pregnant adolescents. Nurs Res 2006;55:402-10.

Dornelas EA, Magnavita J, Beazoglou T, et al. Efficacy and cost-effectiveness of a clinic-based counseling intervention tested in an ethnically diverse sample of pregnant smokers. Patient Educ Couns 2006;64(1-3):342-9.

Gielen AC, Windsor R, Faden RR, et al. Evaluation of a smoking cessation intervention for pregnant women in an urban prenatal clinic. Health Educ Res 1997;12:247-54.

Hartmann KE, Thorp Jr JM, Pahel-Short L, et al. A randomized controlled trial of smoking cessation intervention in pregnancy in an academic clinic. Obstet Gynecol 1996;87:621-6.

Panjari M, Bell R, Bishop S, et al. A randomized controlled trial of a smoking cessation intervention during pregnancy. Aust N Z J Obstet Gynaecol 1999;39:312-7.

Secker-Walker RH, Solomon LJ, Flynn BS, et al. Reducing smoking during pregnancy and postpartum: physician's advice supported by individual counseling. Prev Med 1998;27:422-30.

Walsh RA, Redman S, Brinsmead MW, et al. A smoking cessation program at a public antenatal clinic. Am J Public Health 1997;87:1201-4.

Windsor RA, Lowe JB, Perkins LL, et al. Health education for pregnant smokers: its behavioral impact and cost benefit. Am J Public Health 1993;83:201-6.

Return to Contents

Table 7.8. Meta-analysis (2008): Effectiveness of and estimated pre-parturition abstinence rates for self-help interventions with pregnant smokers (n = 2 studies)

Ershoff DH, Mullen PD, Quinn VP. A randomized trial of a serialized self-help smoking cessation program for pregnant women in an HMO. Am J Public Health 1989;79:182-7.

Hjalmarson AI, Hahn L, Svanberg B. Stopping smoking in pregnancy: effect of a self-help manual in controlled trial. Br J Obstet Gynaecol 1991;98:260-4.

Return to Contents


* Article contributed two studies to the meta-analysis.

Page last reviewed December 2012
Internet Citation: Studies in Meta-analyses (continued, 4). December 2012. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta04.html